Ticker

Molson Coors Beverage (NYSE: TAP.A - Get Free Report) and Arcadia Biosciences (NASDAQ: RKDA - Get Free Report) are both consumer staples companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, valuation, institutional ownership, analyst recommendations, risk and dividends. Valuation and Earnings This table compares

Kirin (OTCMKTS:KNBWY - Get Free Report) and Arcadia Biosciences (NASDAQ: RKDA - Get Free Report) are both consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, analyst recommendations, institutional ownership, dividends, valuation and profitability. Analyst Recommendations This is a summary of current

– Net cash used in operating activities only $319K in the second quarter – – Arcadia closes $4 million private placement; ends second quarter with $4.2 million in cash – – July monthly Zola ® sales top $740K; exceed $1 million through first week of August – DALLAS, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its…

Diageo (NYSE: DEO - Get Free Report) and Arcadia Biosciences (NASDAQ: RKDA - Get Free Report) are both consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation. Profitability This table compares Diageo and Arcadia Biosciences'